Eli Lilly’s pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight loss and diabetes drugs.
Related Posts
Trump aims to cut $6 billion from NASA budget, shifting $1 billion to Mars-focused missions
The Trump administration is floating a plan to trim about $6 billion from the budget of NASA while emphasizing the importance of going to Mars.
Best stocks to play Trump’s AI project Stargate, according to analysts
Here are some of the stocks Wall Street thinks will win under the Stargate joint venture.
Hegseth shared information ahead of Yemen strikes in a Signal chat with wife and brother
The news comes about a month after the editor-in-chief of The Atlantic was mistakenly added to a separate Signal chat with national security leaders.